Narcotic Drugs Global Market Report 2025

Description

A narcotic drug is a class of substances that affect the central nervous system, inducing effects like drowsiness, pain relief, euphoria, and sometimes hallucinations. These drugs are commonly derived from the opium poppy plant but can also be synthesized.

The key types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance derived from the dried latex of immature seed capsules of the opium poppy. These narcotics come from various sources, which can be natural, semi-synthetic, or synthetic, and are used for a range of purposes, including pain management, cough suppression, diarrhea treatment, asthma relief, and more. They are distributed through a variety of channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by diverse end-users, such as hospitals, homecare services, specialty clinics, and others.

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities and any further data you may need to thrive in the narcotic drugs industry. This narcotic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcotic drugs market size has grown steadily in recent years. It will grow from $14.26 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing medical need, growing public health concerns, increasing access to healthcare, rising prevalence of chronic pain, government initiatives to improve pain management.

The narcotic drugs market size is expected to see steady growth in the next few years. It will grow to $17.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing demand for generic narcotic drugs, growing pharmaceutical industry, growing demand for minimally invasive surgeries, increased use of narcotic drugs in palliative care. Major trends in the forecast period include pharmaceutical innovation, telemedicine and remote monitoring, development of non-opioid alternatives, use of artificial intelligence (AI) in drug discovery and development.

The growth of the narcotic drug market is anticipated to be driven by the increasing incidence of chronic diseases. Chronic diseases are defined as illnesses lasting three months or more that can worsen over time. Narcotic drugs play a crucial role in managing these conditions, offering relief for patients suffering from cancer, chronic pain syndrome, terminal illnesses, and severe arthritis. For example, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, marking a significant increase from 3,065,825 in 2022, which is nearly a 20% rise. Consequently, the increasing prevalence of chronic diseases is driving the growth of the narcotic drug market.

The growth of the narcotic drugs market is expected to be significantly influenced by the rising use of opioids as prescription medications. Opioids are a class of drugs that encompass both legal prescriptions and illegal substances, known for inducing feelings of euphoria, relaxation, and sedation. Their increasing use in prescription medicine is a key driver of narcotic drug consumption, as opioids are valued for their powerful pain-relieving and sedative effects, particularly when other pain management methods prove inadequate. For example, in May 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that on a specific day in 2023, there were 53,272 individuals undergoing pharmacotherapy for opioid dependence in Australia (excluding Western Australia), translating to a rate of 22 clients per 10,000 people. Thus, the growing use of opioids as prescription medications is propelling the growth of the narcotic drugs market.

Prominent companies within the narcotic drug market are placing a growing emphasis on product development and innovation to offer dependable products to their customers and bolster their positions in the market. As an example, in May 2023, Indivior PLC, a pharmaceutical company headquartered in the United States, introduced OPVEE (nalmefene) nasal spray. This product serves as an opioid overdose rescue medication designed for use with natural and synthetic opioids, including substances like fentanyl. It is recommended for immediate use in the treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 and older, particularly in cases involving respiratory and central nervous system depression. This development underscores the company's commitment to addressing critical medical needs and enhancing the safety of individuals at risk of opioid overdose.

In March 2023, Indivior PLC, a pharmaceutical company based in the United States, completed its acquisition of Opiant Pharmaceuticals Inc. for a total of $145 million. This strategic acquisition is intended to bolster Indivior PLC's portfolio in the field of addiction treatment and science. It is noteworthy that this acquisition includes OPNT003, an investigational opioid overdose treatment, which is seen as a crucial addition to address the ongoing opioid overdose crisis in the United States, particularly involving potent synthetic opioids like fentanyl. Opiant Pharmaceuticals Inc., a pharmaceutical company headquartered in the United States, specializes in the manufacturing of narcotic drugs. This acquisition reflects Indivior PLC's commitment to expanding its offerings in the fight against opioid overdoses and substance use disorders.

Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the narcotic drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug: Opium; Heroin; Codeine; Oxycodone; Other Drugs
2) By Source: Natural; Semi-Synthetic; Synthetic
3) By Indication: Pain Management; Cough; Diarrhea; Dysentery; Asthma; Other Indications
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Opium: Raw Opium; Opium Extracts; Opium Derivatives
2) By Heroin: Diacetylmorphine; Heroin Hydrochloride; Heroin Acetate
3) By Codeine: Codeine Phosphate; Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride; Oxycodone Acetaminophen; Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl; Morphine; Hydromorphone; Methadone; Buprenorphine
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; AbbVie Inc.; Novartis AG; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28581

1. Executive Summary

2. Narcotic Drugs Market Characteristics

3. Narcotic Drugs Market Trends And Strategies

4. Narcotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Narcotic Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Narcotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Narcotic Drugs Market Growth Rate Analysis
5.4. Global Narcotic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Narcotic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Narcotic Drugs Total Addressable Market (TAM)

6. Narcotic Drugs Market Segmentation

6.1. Global Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Opium
Heroin
Codeine
Oxycodone
Other Drugs
6.2. Global Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural
Semi-Synthetic
Synthetic
6.3. Global Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Cough
Diarrhea
Dysentery
Asthma
Other Indications
6.4. Global Narcotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.6. Global Narcotic Drugs Market, Sub-Segmentation Of Opium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Raw Opium
Opium Extracts
Opium Derivatives
6.7. Global Narcotic Drugs Market, Sub-Segmentation Of Heroin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diacetylmorphine
Heroin Hydrochloride
Heroin Acetate
6.8. Global Narcotic Drugs Market, Sub-Segmentation Of Codeine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Codeine Phosphate
Codeine Sulfate
6.9. Global Narcotic Drugs Market, Sub-Segmentation Of Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oxycodone Hydrochloride
Oxycodone Acetaminophen
Controlled-Release Oxycodone
6.10. Global Narcotic Drugs Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fentanyl
Morphine
Hydromorphone
Methadone
Buprenorphine

7. Narcotic Drugs Market Regional And Country Analysis

7.1. Global Narcotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Narcotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Narcotic Drugs Market

8.1. Asia-Pacific Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Narcotic Drugs Market

9.1. China Narcotic Drugs Market Overview
9.2. China Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Narcotic Drugs Market

10.1. India Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Narcotic Drugs Market

11.1. Japan Narcotic Drugs Market Overview
11.2. Japan Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Narcotic Drugs Market

12.1. Australia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Narcotic Drugs Market

13.1. Indonesia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Narcotic Drugs Market

14.1. South Korea Narcotic Drugs Market Overview
14.2. South Korea Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Narcotic Drugs Market

15.1. Western Europe Narcotic Drugs Market Overview
15.2. Western Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Narcotic Drugs Market

16.1. UK Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Narcotic Drugs Market

17.1. Germany Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Narcotic Drugs Market

18.1. France Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Narcotic Drugs Market

19.1. Italy Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Narcotic Drugs Market

20.1. Spain Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Narcotic Drugs Market

21.1. Eastern Europe Narcotic Drugs Market Overview
21.2. Eastern Europe Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Narcotic Drugs Market

22.1. Russia Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Narcotic Drugs Market

23.1. North America Narcotic Drugs Market Overview
23.2. North America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Narcotic Drugs Market

24.1. USA Narcotic Drugs Market Overview
24.2. USA Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Narcotic Drugs Market

25.1. Canada Narcotic Drugs Market Overview
25.2. Canada Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Narcotic Drugs Market

26.1. South America Narcotic Drugs Market Overview
26.2. South America Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Narcotic Drugs Market

27.1. Brazil Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Narcotic Drugs Market

28.1. Middle East Narcotic Drugs Market Overview
28.2. Middle East Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Narcotic Drugs Market

29.1. Africa Narcotic Drugs Market Overview
29.2. Africa Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Narcotic Drugs Market Competitive Landscape And Company Profiles

30.1. Narcotic Drugs Market Competitive Landscape
30.2. Narcotic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Narcotic Drugs Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Takeda Pharmaceutical Company Limited
31.3. Boehringer Ingelheim International GmbH
31.4. Viatris Inc.
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Daiichi Sankyo Company Limited
31.7. Sun Pharmaceutical Industries Ltd.
31.8. Purdue Pharma LP
31.9. Hikma Pharmaceuticals Plc
31.10. Endo Pharmaceuticals Inc.
31.11. Amneal Pharmaceuticals LLC
31.12. Lupin Ltd.
31.13. Mallinckrodt Pharmaceuticals
31.14. Alvogen Inc.
31.15. Indivior Inc.

32. Global Narcotic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Narcotic Drugs Market

34. Recent Developments In The Narcotic Drugs Market

35. Narcotic Drugs Market High Potential Countries, Segments and Strategies

35.1 Narcotic Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Narcotic Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Narcotic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer